Schedule 13D ownership disclosure

PERNIX THERAPEUTICS HOLDINGS, INC.

Security class unavailable · CUSIP: 71426V108

Event date: 2015-07-22

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
4.9100%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-15-264182
Form type
SC 13D/A
Filer
Athyrium Opportunities Fund (A) LP
CIK
CIK 1589714
Filed
Jul 27, 2015
Reporting period
Jul 22, 2015
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub